Navigation Links
Auxilium Pharmaceuticals to Present at the Morgan Stanley 2011 Healthcare Conference
Date:8/31/2011

MALVERN, Pa., Aug. 31, 2011 /PRNewswire/ -- Auxilium Pharmaceuticals, Inc. (Nasdaq: AUXL) today announced that executive management will participate in the Morgan Stanley 2011 Healthcare Conference during September 13-14, 2011 at the Grand Hyatt New York.  Mr. Armando Anido, Chief Executive Officer and President, is scheduled to present an overview of the Company and its product pipeline at 8:35 am ET on Wednesday, September 14, 2011.  

(Logo  http://photos.prnewswire.com/prnh/20101202/MM10881LOGO )

To listen to the audio webcast of the presentation during or after the event, please visit: http://www.auxilium.com. The replays will be available for ninety days after the event.

About Auxilium

Auxilium Pharmaceuticals, Inc. is a specialty biopharmaceutical company with a focus on developing and marketing products to predominantly specialist audiences, such as urologists, endocrinologists, certain targeted primary care physicians, hand surgeons, subsets of orthopedic, general, and plastic surgeons who focus on the hand, and rheumatologists. Auxilium markets XIAFLEX® (collagenase clostridium histolyticum) for the treatment of adult Dupuytren's contracture patients with a palpable cord and Testim® 1%, a testosterone gel, for the topical treatment of hypogonadism in the U.S. Pfizer Inc. has marketing rights for XIAPEX® (the EU tradename for collagenase clostridium histolyticum) in 46 countries in Eurasia and Asahi Kasei Pharma Corporation has development and commercial rights for XIAFLEX in Japan. Ferring International Center S.A. markets Testim in the EU and Paladin Labs Inc. markets Testim in Canada. Auxilium has two projects in clinical development. XIAFLEX is in phase III of development for the treatment of Peyroni
'/>"/>

SOURCE Auxilium Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Auxilium Pharmaceuticals, Inc. Updates Launch Progress of XIAPEX® in EU
2. Auxilium Pharmaceuticals, Inc. Announces First Quarter 2011 Financial Results and Operational Highlights
3. Auxilium Pharmaceuticals to Announce First Quarter 2011 Results and Conduct Conference Call on Monday, May 9, 2011
4. Auxilium Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2010 Financial Results, Guidance for 2011
5. Auxilium Pharmaceuticals to Announce Fourth Quarter and Full Year 2010 Results and Conduct Conference Call on Thursday, February 10, 2011
6. Questcor Pharmaceuticals to Present at Upcoming Investor Conferences in September
7. Planet Biopharmaceuticals, Inc. Appoints Theron (Ted) Odlaug, Ph.D. as Executive Chairman
8. Syndax Pharmaceuticals Announces Issuance of EU Patent for Entinostat
9. Anadys Pharmaceuticals to Report Second Quarter 2011 Financial Results
10. Optimer Pharmaceuticals to Present at the Canaccord Genuity Annual Growth Conference
11. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Second Quarter 2011 Financial Results on August 3, 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... ALBANY, N.Y. , June 18, 2013 /PRNewswire/ ... that its Burlington, Mass. , ... U.S. Drug Enforcement Administration (DEA) registration to handle ... represents the DEA,s acknowledgement of Burlington,s ... inventory control and documentation. (Logo: ...
(Date:6/18/2013)...  Techne Corporation (NASDAQ: TECH ) ... acquire 100% ownership of Bionostics Holdings Limited and ... a global leader in the development, manufacture and ... operation of in vitro diagnostic (IVD) ... glucose and blood gas testing.  Biosnostics has strategic ...
(Date:6/18/2013)... Research and Markets ... of the "Injectable Drug Delivery Market ... [Disposables & Reusable, Fillable & Prefilled, Pen, ... [Diabetes & Oncology] - Global Forecasts to ...      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , , ,The ...
(Date:6/18/2013)... June 18, 2013 ... ) has announced the addition of ... & Stable Isotopes Market [SPECT/PET Radioisotopes ... Y-90)], [Applications (Cancer/Oncology, Cardiac)] & (Deuterium, ... report to their offering. ...
Breaking Biology Technology:AMRI Burlington Receives DEA Approval to Handle Controlled Substances 2Techne Corporation Announces Acquisition Agreement 2Techne Corporation Announces Acquisition Agreement 3Techne Corporation Announces Acquisition Agreement 4Techne Corporation Announces Acquisition Agreement 5Injectable Drug Delivery Market by Formulations, Devices & Therapeutics - Global Forecasts to 2017 2Injectable Drug Delivery Market by Formulations, Devices & Therapeutics - Global Forecasts to 2017 3North American Nuclear Medicine/Radiopharmaceuticals & Stable Isotopes Market - Forecast to 2017 2North American Nuclear Medicine/Radiopharmaceuticals & Stable Isotopes Market - Forecast to 2017 3
... Enerkem one step closer to becoming the, ... use waste, feedstock,MONTREAL, Jan. 12 /PRNewswire/ ... technology company, announced today that its first commercial-scale plant ... with the production of its clean conditioned synthesis gas. ...
... Biosystems,Inc. (OTC Bulletin Board: WGBS), a leading ... and stem cell research systems, today,announced that ... the company,s SmartChip(TM) Real-Time PCR System in ... testing program. Initial tests,conducted at the ...
... Board of Directors of SemBioSys Genetics Inc. (TSX:SBS), ... plants, today announced that current President and CEO ... position of President and CEO of Botaneco Specialty ... the corporation,s Chief Financial Officer, has been named ...
Cached Biology Technology:Enerkem announces first commercial-scale biofuels and biochemicals plant is entering start-up phase 2Enerkem announces first commercial-scale biofuels and biochemicals plant is entering start-up phase 3WaferGen's SmartChip(TM) System Performance Successfully Demonstrated in Initial Phase of Alpha Testing Program 2WaferGen's SmartChip(TM) System Performance Successfully Demonstrated in Initial Phase of Alpha Testing Program 3WaferGen's SmartChip(TM) System Performance Successfully Demonstrated in Initial Phase of Alpha Testing Program 4WaferGen's SmartChip(TM) System Performance Successfully Demonstrated in Initial Phase of Alpha Testing Program 5SemBioSys announces senior management changes 2SemBioSys announces senior management changes 3SemBioSys announces senior management changes 4
(Date:6/17/2013)... understand the concept of improving original foundations with more ... the University of Pittsburgh,s Kenneth P. Dietrich School of ... that could make drug delivery, gas storage, and gas ... findings were reported in the latest issue of the ... JACS ). , The recent work builds upon Pitt ...
(Date:6/17/2013)... A Kansas State University research associate has received a ... ways to prevent the spread of malaria. , Bart ... Institutes of Health,s National Research Service Award Individual Postdoctoral ... the seventh Kansas State University researcher to receive the ... currently hold such an award. , Bryant, a university ...
(Date:6/17/2013)... Fracking, the controversial method of mining shale gas, is ... the Appalachian Basin. New research in the Annals ... the threat posed to biodiversity including pollution from toxic ... changes to wetlands. , "Shale gas has engendered a ... on human health, but effects on biological diversity and ...
Breaking Biology News(10 mins):'Chemical architects' build materials with potential applications in drug delivery and gas storage 2NIH fellowship helps researcher fight malaria, understand mosquito immunity 2
... trial launched in Pittsburgh, Pennsylvania today, with sites preparing ... Scientists will test the rectal safety and acceptability of ... has shown promise for preventing HIV through vaginal intercourse. ... gel could be further evaluated to determine if it ...
... its primitive structure, the North American comb jellyfish can ... submarine, making it a successful predator. Researchers, including one ... to show how the jellyfish makes itself hydrodynamically ,invisible,. ... has long been known to consume vast quantities ...
... 2010 A research team at Ben-Gurion University of the ... detected a genetic mutation resulting in a progressive disease of ... research was just published in the American Journal of ... Ohad Birk of the National Institute for Biotechnology in the ...
Cached Biology News:International Rectal Microbicide Advocates cheers launch of world's third rectal microbicide trial 2International Rectal Microbicide Advocates cheers launch of world's third rectal microbicide trial 3Voracious comb jellyfish 'invisible' to prey 2Genetic defect found to cause severe epilepsy and mental retardation 2
... The Fujifilm Life Science LAS-3000 ... technology with a simplified user interface, ... a wide range of modularities. The ... for a wide range of applications ...
... range of ergonomic microscopes are now available ... footprint. The DM-BA200 comes packed with Motic's ... exchangeable USB2.0 plug and play digital image ... mounted on a reversed quadruple nosepiece, deliver ...
... Ion Chromatography requirements, IonQuest will provide ... newly developed conductivity detector has very ... In addition to the standard conductivity ... other detectors, such as electrochemical, refractive index, ...
... The Fujifilm Life Science LAS-3000mini ... especially dedicated to chemiluminescence applications, and ... blotting applications., Fuiji 's LAS-3000 provides ... and digitization. , Glowell calibration standards ...
Biology Products: